1. This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More.

Myalept Approved by FDA

Discussion in 'Forex Daily News & Outlook' started by MTnews, Feb 25, 2014.

  1. MTnews

    MTnews Content Contributor

    Joined:
    Dec 17, 2007
    Messages:
    810
    Likes Received:
    0
    Daily Market Commentary for February 25, 2014

    Bristol-Myers Squibb Company (BMY) received approval from the U.S. Food and Drug Administration on February 24 for Myalept (metreleptin for injection) as replacement therapy to treat the complications of leptin deficiency in patients with congenital generalized or acquired generalized lipodystrophy.

    read more at:http://www.millennium-traders.com/news/newscommentary.aspx


    Thanks for reading
    Millennium-Traders.Com
    http://www.millennium-traders.com
     

Share This Page